Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi - Oncology Drug Advisory Committee - Document - PDFSEARCH.IO

First Page		Document Content
Melanoma Ipilimumab Response Evaluation Criteria in Solid Tumors		Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 605,19 KB Share Document on Facebook